Short answer first

Full clinical reasoning

1. Pharmacokinetics of Lorazepam 2 mg IM at 1 hour post-dose

• IM lorazepam has an onset of 15-30 minutes and reaches peak plasma concentration at approximately 1-1.5 hours post-IM injection.
• Half-life is 10-20 hours (Kaplan & Sadock's, benzodiazepine pharmacology table).
• At 1 hour post-IM, the patient is essentially at or very near peak lorazepam levels - the drug is maximally active right now.
• Lorazepam 2 mg IM is itself a substantial anxiolytic/sedating dose. In terms of approximate benzodiazepine equivalence: lorazepam 1 mg ≈ alprazolam 0.5 mg, so lorazepam 2 mg IM ≈ alprazolam 4 mg in equivalent anxiolytic effect.

2. What alprazolam 0.25 mg adds

• Alprazolam 0.25 mg is a low dose (its therapeutic range is 0.25-4 mg/day), but adding any benzodiazepine on top of peak lorazepam effect is pharmacodynamically additive.
• Both act on the same GABA-A receptor, enhancing chloride conductance. There is no synergistic benefit in panic - you are simply adding more drug to an already occupied receptor system.
• The anxiolytic "extra kick" from 0.25 mg alprazolam when 2 mg lorazepam IM is already aboard is clinically negligible, while the additive CNS depressant risk is real.

3. Risks of combining

• Excessive sedation / obtundation - the most common outcome
• Respiratory depression - especially relevant if the patient has any respiratory compromise, has taken alcohol, opioids, or other CNS depressants
• Hypotension, ataxia, loss of protective airway reflexes
• Paradoxical excitation can occur in some patients with high-dose benzodiazepines
• Alprazolam is metabolized by CYP3A4, while lorazepam undergoes direct glucuronidation - so no significant pharmacokinetic interaction, but the pharmacodynamic (additive CNS depression) risk is still present

4. What to do instead

5. Special populations - extra caution

• Elderly patients: Beers criteria explicitly flag both alprazolam and lorazepam as high-risk in elderly; combining them is especially dangerous
• Respiratory disease (COPD, OSA): Benzodiazepine stacking is relatively contraindicated
• Opioid co-administration: Adding alprazolam to lorazepam in any patient who has opioids aboard carries black-box warning level risk of fatal respiratory depression

Bottom line

Clinical note: If you are working in an acute/emergency setting, ensure continuous monitoring of respiratory rate, SpO2, and level of consciousness - flumazenil should be available if benzodiazepine over-sedation occurs. Flumazenil reverses benzodiazepine effects at the GABA-A receptor.

• Kaplan & Sadock's Comprehensive Textbook of Psychiatry, Benzodiazepine Pharmacologic Actions table
• Goodman & Gilman's Pharmacological Basis of Therapeutics, Clinical Considerations With Anxiolytic Drugs
• Adams and Victor's Principles of Neurology, 12th Ed., Treatment section

Options when a patient still can't sleep after Lorazepam 2 mg IM

First - reassess before adding more drugs

• Is the lorazepam still climbing to peak? (IM onset 15-30 min, peak ~1-1.5 hours) - if <90 minutes, wait.
• Is there a reversible cause keeping them awake? Pain, urinary retention, noise, anxiety catastrophizing, caffeine, or fear/hyperarousal?
• Is the "panic" actually resolved but the arousal/hypervigilance persists? These need different approaches.

Pharmacological options (by class)

1. Z-drugs - GABA-A selective hypnotics (first-line add-on)

• Z-drugs act on GABA-A receptors but more selectively than benzodiazepines (alpha-1 subunit preference).
• Since lorazepam already occupies GABA-A receptors, use lowest dose of Z-drug - there is still additive CNS/respiratory depression risk, but it is less than adding another benzodiazepine.
• Stahl's Essential Psychopharmacology: "zolpidem CR extends duration of action from ~2-4 hours to 6-8 hours, improving sleep maintenance."

2. Dual Orexin Receptor Antagonists - DORAs (safest add-on mechanistically)

• DORAs work by a completely different mechanism - they block wake-promoting orexin (hypocretin) signals rather than enhancing GABA inhibition.
• Stahl's: DORAs work "without the side effects expected of a benzodiazepine or Z-drug hypnotic, namely lacking dependence, withdrawal, rebound, unsteady gait, falls, confusion, amnesia, or respiratory depression."
• This is the theoretically cleanest option to add when a benzodiazepine has already been given - no additive respiratory depression risk. Limited in acute Indian settings due to availability/cost.

3. Sedating antihistamines (practically useful, widely available)

• Promethazine is widely used in acute psychiatric/emergency settings in India. Does not cause respiratory depression on its own, but adds to CNS depression when combined with benzodiazepines - monitor accordingly.
• Hydroxyzine is a reasonable anxiolytic-sedative with a cleaner safety profile.

4. Low-dose sedating antipsychotic (if anxious arousal/agitation persists)

• Low-dose quetiapine (25 mg) is commonly used off-label for insomnia in psychiatric inpatients - works primarily through H1 histamine blockade at low doses.
• No respiratory depression risk unlike benzodiazepines.
• Useful if panic has an agitation or psychotic component.

5. Melatonin / Melatonin receptor agonists

• Melatonin is safe, has no interaction with benzodiazepines, and is appropriate when circadian dysregulation or hyperarousal (rather than true anxiety) is the main driver.
• Goodman & Gilman's: "Binding of agonists such as melatonin to MT1 receptors promotes the onset of sleep."
• Best for situations where the lorazepam has calmed the panic but the patient simply cannot "switch off."

6. Sedating antidepressants (if ongoing management is being planned)

• Mirtazapine at 7.5-15 mg is one of the most potent sleep-inducers in psychiatry with minimal respiratory depression risk.
• Trazodone is widely used in inpatient settings for insomnia without dependence risk.

Practical decision algorithm for your setting

Lorazepam 2 mg IM given → still awake at 90+ min
        ↓
Is there residual anxiety/panic driving wakefulness?
  YES → Hydroxyzine 25-50 mg OR Quetiapine 25 mg oral
  NO (just can't sleep/hyperarousal) → Zopiclone 7.5 mg OR Melatonin 5-10 mg
        ↓
Agitation component? → Olanzapine 5 mg oral/IM OR Haloperidol 2.5 mg IM

What to avoid

• Another benzodiazepine (alprazolam, clonazepam, diazepam) - additive CNS/respiratory depression, no extra benefit
• Barbiturates - narrow therapeutic window, no role here
• High-dose antihistamines in elderly - Beers criteria concern (confusion, falls)

1. Zopiclone 7.5 mg (if not already given, and >90 min after lorazepam)
2. Promethazine 25 mg (widely available, strong sedation - monitor vitals)
3. Quetiapine 25 mg (if agitation/arousal component)
4. Melatonin 5 mg (safest, no interaction, good for pure hyperarousal insomnia)

• Stahl's Essential Psychopharmacology, Z-drugs and DORAs sections
• Kaplan & Sadock's Comprehensive Textbook of Psychiatry, Sleep pharmacology
• Goodman & Gilman's, Melatonin receptor agonists section

Can an MBBS doctor prescribe Quetiapine in India?

1. Drug Schedule Status of Quetiapine in India

• Schedule H = "Prescription-only" drugs - can only be dispensed on the prescription of a Registered Medical Practitioner (RMP)
• An MBBS graduate registered with the State Medical Council is a full RMP under Indian law
• Quetiapine is NOT in Schedule H1 (which covers certain antibiotics, anti-TB drugs, habit-forming psychotropics like benzodiazepines) and is NOT in Schedule X (the most restricted narcotics/psychotropics)
• Therefore, no special license or specialist registration is needed to prescribe it - any RMP can legally do so

Wikipedia's Schedule H list explicitly includes "QUETIAPINE FUMERATE" as a standard Schedule H drug.

2. Regulatory Position - What the Law Says

3. Practical / Professional Considerations

• Competency - An MBBS doctor is expected to prescribe within their competence. Quetiapine has a complex side effect profile:
  • QTc prolongation (ECG monitoring recommended)
  • Metabolic syndrome (blood glucose, lipids)
  • Extrapyramidal symptoms, tardive dyskinesia (less than first-gen antipsychotics)
  • Orthostatic hypotension - especially relevant in acute settings
• For acute sleep/panic in your context - quetiapine 25 mg is a low, commonly used dose even in general hospital settings and is within routine MBBS-level competency
• For ongoing psychiatric illness (schizophrenia, bipolar, treatment-resistant depression) - ideally refer to or co-manage with a psychiatrist, though legally an MBBS can still prescribe
• Documentation - As with all psychotropic prescriptions, document indication, informed consent discussion, and monitoring plan

4. The Short Answer for Your Clinical Scenario

Yes, you can prescribe quetiapine 25 mg for acute insomnia/anxiety in a monitored inpatient/acute setting. It is Schedule H, not H1 or X, so it only needs a valid RMP prescription - which an MBBS doctor provides. Just document your indication, check baseline vitals and ECG if possible, and monitor for oversedation (especially since lorazepam was already given).